Skip to Main Content

Paper Details

Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
J Clin Oncol
75
2021
Author NameAffiliation
Karyn A GoodmanIcahn School of Medicine at Mount Sinai
Fang-Shu OuMayo Clinic
  • 1 - 2

Datasets

Release 1.2